MaxCyte (NASDAQ:MXCT – Get Rating) and SomaLogic (NASDAQ:SLGC – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Insider and Institutional Ownership 65.9% of MaxCyte shares are held by […]